| Literature DB >> 35062669 |
Abid Ali1,2, Shabir Ahmad2, Pedro Machado Medeiros de Albuquerque2, Atif Kamil3, Fahdah Ayed Alshammari4, Abdulaziz Alouffi5,6,7, Itabajara da Silva Vaz2.
Abstract
The emergence of drug-resistant lice, acari, and their associated pathogens (APs) is associated with economic losses; thus, it is essential to find new appropriate therapeutic approaches. In the present study, a subtractive proteomics approach was used to predict suitable therapeutics against these vectors and their infectious agents. We found 9701 proteins in the lice (Pediculus humanus var. corporis) and acari (Ixodes scapularis, Leptotrombidium deliense), and 4822 proteins in the proteomes of their APs (Babesia microti, Borreliella mayonii, Borrelia miyamotoi, Borrelia recurrentis, Rickettsia prowazekii, Orientia tsutsugamushi str. Boryong) that were non-homologous to host proteins. Among these non-homologous proteins, 365 proteins of lice and acari, and 630 proteins of APs, were predicted as essential proteins. Twelve unique essential proteins were predicted to be involved in four unique metabolic pathways of lice and acari, and 103 unique proteins were found to be involved in 75 unique metabolic pathways of APs. The sub cellular localization analysis of 115 unique essential proteins of lice and acari and their APs revealed that 61 proteins were cytoplasmic, 42 as membrane-bound proteins and 12 proteins with multiple localization. The druggability analysis of the identified 73 cytoplasmic and multiple localization essential proteins revealed 22 druggable targets and 51 novel drug targets that participate in unique pathways of lice and acari and their APs. Further, the predicted 42 membrane bound proteins could be potential vaccine candidates. Screening of useful inhibitors against these novel targets may result in finding novel compounds efficient for the control of these parasites.Entities:
Keywords: acari; drug targets; essential gene; lice; subtractive analysis; vaccine candidates
Year: 2021 PMID: 35062669 PMCID: PMC8778234 DOI: 10.3390/vaccines10010008
Source DB: PubMed Journal: Vaccines (Basel) ISSN: 2076-393X
Figure 1Flowchart of B-cell linear epitope prediction.
The stepwise analysis and their result of selected vectors.
| Steps |
|
| |
|---|---|---|---|
| Host | |||
|
|
|
| |
| Total proteome | 20,467 | 10,775 | 14,667 |
| Duplicates (>60% identical) in CD-HIT | 14,618 | 9726 | 11,328 |
| Non-homologs | 5619 | 2210 | 1872 |
| Essential proteins in DEG | 169 | 120 | 76 |
| Unique metabolic pathway KEGG | 1 | 3 | - |
| Essential Proteins involved KEGG and KAAS | 1 | 1 | 10 |
| Druggability with cutoff E-value 10−5 | 0 | 0 | 1 |
Subtractive proteome analysis and metabolic pathway results of lice, acari, and their associated pathogens.
| Steps |
|
|
| |||
|---|---|---|---|---|---|---|
| Host | ||||||
|
|
|
|
|
|
| |
| Total proteome | 3601 | 1133 | 1118 | 1012 | 843 | 1085 |
| Duplicates (>60% identical) in CD-HIT | 3363 | 922 | 906 | 890 | 772 | 731 |
| Non-homologs | 1780 | 704 | 696 | 677 | 492 | 473 |
| Essential proteins in DEG | 106 | 95 | 121 | 119 | 95 | 94 |
| Unique metabolic pathway KEGG | 3 | 15 | 8 | 16 | 21 | 12 |
| Essential Proteins involved KEGG and KAAS | - | 23 | 25 | 23 | 18 | 14 |
| Druggability with cutoff E-value 10−5 | - | 5 | 8 | 6 | 6 | 3 |
Figure 2Unique non-homologous essential proteins in the unique metabolic pathway of (A) Borrelia recurrentis, (B) Orientia tsutsugamushi str. Boryong, (C) Rickettsia prowazekii str. Madrid E, (D) Borreliella mayonii, and (E) Borrelia miyamotoi.
Figure 3Cellular localization of the essential protein in lice, acari, and their associated pathogens.
Figure 4Protein–protein interaction of protein using string database. Nodes of the network represent protein while protein–protein interaction are presented by edges. The red colors show the query proteins and first shell of interaction, and the white nodes show the second level of interaction. Empty nodes show proteins of unknown 3D structure, and filled nodes show proteins of known or predicted 3D structure. (A) phospho-N-acetylmuramoyl-pentapeptide-transferase membrane proteins (Rickettsia prowazekii str. Madrid E). (B) UDP-N-acetylenolpyruvoylglucosamine reductase membrane proteins of Orientia tsutsugamushi str. Boryong. (C) conjugal transfer protein membrane proteins of O. tsutsugamushi str. Boryong. (D) Phospho-N-acetylmuramoyl-pentapeptide-transferase membrane proteins of O. tsutsugamushi str. Boryong. (E) Type IV secretion system protein membrane proteins of O. tsutsugamushi str. Boryong. (F) phospho-N-acetylmuramoyl-pentapeptide-transferase of Borrelia miyamotoi, (G) flagellar type III secretion system pore protein FliP of B. miyamotoi, and (H) phospho-N-acetylmuramoyl-pentapeptide-transferase of Borreliella mayonii.
Figure 5The three-dimensional structure of the protein was predicted by I-TASSER and Discontinuous epitope prediction of the putative epitopes identified by ElliPro (left and with colored epitopes) and DiscoTope (right and epitopes in brown). (A) UDP-N-acetylmuramate dehydrogenase (Orientia tsutsugamushi; WP_011944569.1), (B) Type IV secretion system protein (O. tsutsugamushi; WP_011945117.1), (C) Phospho-N-acetylmuramoyl-pentapeptide-transferase (Borrelia recurrentis; WP_012538808.1), (D) Phospho-N-acetylmuramoyl-pentapeptide-transferase (Rickettsia prowazekii str. Madrid E; NP_220963.1), (E) Phospho-N-acetylmuramoyl-pentapeptide-transferase (O. tsutsugamushi; WP_011944610.1), (F) Type IV secretion system protein (O. tsutsugamushi; WP_011944382.1), (G) phospho-N-acetylmuramoyl-pentapeptide-transferase (Borrelia miyamotoi; WP_020954693.1), (H) flagellar type III secretion system pore protein FliP (B. miyamotoi; WP_020954665.1) and (I) phospho-N-acetylmuramoyl-pentapeptide-transferase (Borreliella mayonii; WP_075552002.1).